Connection

DEBRA PALAZZI to Child, Preschool

This is a "connection" page, showing publications DEBRA PALAZZI has written about Child, Preschool.
Connection Strength

0.535
  1. Factors Associated With Penicillin Allergy Labels in Electronic Health Records of Children in 2 Large US Pediatric Primary Care Networks. JAMA Netw Open. 2022 03 01; 5(3):e222117.
    View in: PubMed
    Score: 0.064
  2. Clinical Impact of Plasma Metagenomic Next-generation Sequencing in a Large Pediatric Cohort. Pediatr Infect Dis J. 2022 02 01; 41(2):166-171.
    View in: PubMed
    Score: 0.064
  3. Risk factors for microbiologic failure in children with Enterobacter species bacteremia. PLoS One. 2021; 16(10):e0258114.
    View in: PubMed
    Score: 0.062
  4. The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis. Ther Drug Monit. 2018 06; 40(3):322-329.
    View in: PubMed
    Score: 0.049
  5. Pediatric Neglected Tropical Diseases in a Major Metropolitan Children's Hospital in the United States, 2004-2013. J Pediatric Infect Dis Soc. 2016 Dec; 5(4):470-472.
    View in: PubMed
    Score: 0.041
  6. Candida speciation, antifungal treatment and adverse events in pediatric invasive candidiasis: results from 441 infections in a prospective, multi-national study. Pediatr Infect Dis J. 2014 Dec; 33(12):1294-6.
    View in: PubMed
    Score: 0.039
  7. Risk factors of amphotericin B toxicty in the nonneonatal pediatric population. Pediatr Infect Dis J. 2012 Sep; 31(9):910-4.
    View in: PubMed
    Score: 0.033
  8. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J. 2011 Aug; 30(8):664-8.
    View in: PubMed
    Score: 0.031
  9. Altered gentamicin serum concentrations in obese pediatric patients. Pediatr Infect Dis J. 2011 Apr; 30(4):347-9.
    View in: PubMed
    Score: 0.030
  10. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis. Pharmacotherapy. 2010 Mar; 30(3):248-53.
    View in: PubMed
    Score: 0.028
  11. Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network. J Pediatric Infect Dis Soc. 2024 Dec 30; 13(12):633-638.
    View in: PubMed
    Score: 0.019
  12. Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis. 2003 Feb 01; 36(3):306-12.
    View in: PubMed
    Score: 0.017
  13. Rat Lungworm Infection Associated with Central Nervous System Disease - Eight U.S. States, January 2011-January 2017. MMWR Morb Mortal Wkly Rep. 2018 Aug 03; 67(30):825-828.
    View in: PubMed
    Score: 0.012
  14. Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age. Pediatr Infect Dis J. 2017 07; 36(7):645-653.
    View in: PubMed
    Score: 0.012
  15. Failure to Validate a Multivariable Clinical Prediction Model to Identify Pediatric Intensive Care Unit Patients at High Risk for Candidemia. J Pediatric Infect Dis Soc. 2016 Dec; 5(4):458-461.
    View in: PubMed
    Score: 0.010
  16. Modification of an evidence-based protocol for advanced appendicitis in children. J Surg Res. 2013 Nov; 185(1):273-7.
    View in: PubMed
    Score: 0.009
  17. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J. 2012 Dec; 31(12):1252-7.
    View in: PubMed
    Score: 0.008
  18. A clinical analysis of shoulder and hip joint infections in children. J Pediatr Orthop. 2009 Oct-Nov; 29(7):828-33.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.